In this study, we want to see if a new drug called petosemtamab is effective. The study is for patients who have head and neck cancer that has spread or come back and cannot be cured. We want to see if petosemtamab works better than the treatments doctors usually use.
Thank you for your interest, but this study will start enrolling soon.
United States (Nationwide)
Sid Sheth
Lineberger Comprehensive Cancer Center
Clinical or Medical
Interventional
Cancer (Head and Neck)
24-1875
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
